Akero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis, with positive 96-week phase 2b data published in NEJM. The SYNCHRONY phase 3 program targets a broad MASH population, positioning Akero for significant market opportunity and acquisition interest. GlaxoSmithKline's $1.2B acquisition of FGF21 asset validates the value of Akero's approach and increases likelihood of a strategic buyout occurring.
13 Aug 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
20 May 2025 Date | | - Cons. EPS | - EPS |
7 Nov 2024 Date | | - Cons. EPS | 15.06 EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
13 Aug 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
20 May 2025 Date | | - Cons. EPS | - EPS |
7 Nov 2024 Date | | - Cons. EPS | 15.06 EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
8 Aug 2024 Date | | - Cons. EPS | - EPS |
Insurance - Diversified Industry | Financial Services Sector | Daniel Kyle Cerminara CFA CEO | NASDAQ (NMS) Exchange | 30259W104 Cusip |
US Country | 130 Employees | - Last Dividend | 1 Nov 2024 Last Split | 1 Apr 2014 IPO Date |
Fundamental Global Inc., formerly known as Ballantyne Strong, Inc., is a diversified company that operates in the reinsurance, merchant banking, and asset management sectors. The company underwent a name change to FG Group Holdings Inc. in December 2022, marking a significant milestone in its history since its founding in 1932. Based in Mooresville, North Carolina, Fundamental Global Inc. has built a robust portfolio of services designed to meet the complex needs of its clients across various sectors. With a long-standing history and a redefined focus, the company aims to leverage its expertise and broad service offerings to sustain its growth and market presence.
Fundamental Global Inc. provides expert guidance and support for companies looking to go public. Their services cover the entire process of an initial public offering (IPO), including regulatory compliance, market positioning, and capital raising strategies. This offering is tailored for organizations seeking to navigate the complexities of entering the public markets efficiently.
The company offers reinsurance solutions that are specialized in the areas of property and casualty. This service is designed to help insurance companies manage their risks and liabilities by providing them with reinsurance products that mitigate potential losses related to property and casualty claims. Through this offering, Fundamental Global Inc. aims to support the stability and financial integrity of its clients in the insurance sector.
With a dedicated asset management arm, Fundamental Global Inc. provides comprehensive investment advisory services. These services aim to assist individuals, families, and institutions in achieving their investment objectives through strategic asset allocation, portfolio management, and financial planning. The expertise offered by the company covers a wide range of asset classes and investment vehicles, tailored to meet the specific needs and risk tolerance of each client.